An NHC–Cu complex catalyzed the asymmetricconjugateaddition (ACA) of various Grignard reagents to nonactivated α-substituted cyclic enones to give 2,3-dialkylated cyclopentanones and cyclohexanones. The Michael addition features the formation of a magnesium enolate intermediate. One-pot diastereoselective trapping of this enolate by alkyl, propargyl, allyl, and benzyl halides led to ketones with
Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Medical Disorders
申请人:Achillion Pharmaceuticals, Inc.
公开号:US20170066783A1
公开(公告)日:2017-03-09
Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R
12
or R
13
on the A group is an aryl, heteroaryl or heterocycle (R
32
) are provided. The inhibitors of Factor D described herein reduce the excessive activation of complement.
LUCCHETTI J.; KRIEF A., TETRAHEDRON LETT., 1981, 22, NO 17, 1623-1626